Although the proliferative effects of hematopoietic cytokines on erythroid progenitors are well known, parameters that influence the initiation of expression of specialized or lineage-restricted genes are not clear. We have studied the acquisition of erythroid-differentiative features from enriched populations of human early erythroid progenitors (burst-forming unit-erythroid [BFUe]) in suspension culture and the influence of several cytokines on this process. In suspension cultures containing no erythropoietin (Epo), we have found that kit ligand (KL) in synergy with interleukin-3 not only increases the proliferation of cells and of progenitors but also consistently amplifies a population of cells that contain globin within 1 week. Our experiments suggest that neither extraneously provided nor endogenously produced Epo is critical for the generation of globin-synthesizing cells. Globin-producing cells generated mostly from late BFUe or pre-CFUe with a CD34-/EP-1+ phenotype in this EMATOPOIETIC progenitors require a range of he-H matopoietic cytokines for their optimal development and terminal differentiation.'" Interleukin-3 (IL-3), kit ligand (KL; or Steel factor, SCF, or MGF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) exert, especially in synergy, a profound proliferative influence on all hematopoietic progenitors, whereas several late acting cytokines (such as granulocyte-CSF [G-CSF] and erythropoietin [Epo]) are crucial for the maturation of specialized progeny from these progenitors. As pure recombinant factors are now available and highly enriched populations of hematopoietic progenitors can be obtained for testing, their growth requirements have been further refined."" Most of the informati6n has been deduced using clonal assay systems for progenitors and has relied on the recognition of terminally differentiated progeny. Recently, in addition to these systems, suspension cultures have been used for the characterization of erythroidL6-l9 or granulocytic progenitor~.l~-~~ These systems are easier to manipulate and have confirmed to a large extent the growth requirements of progenitors and the factors needed for their amplification. However, because the results so far have been evaluated in end-stage progeny of these progenitors and because the culture systems used may contain undefined as well as defined factors, the implementation of the early transition from the progenitor stage to the stage of lineagespecific gene expression has not yet been delineated.
H matopoietic cytokines for their optimal development and terminal differentiation.'" Interleukin-3 (IL-3), kit ligand (KL; or Steel factor, SCF, or MGF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) exert, especially in synergy, a profound proliferative influence on all hematopoietic progenitors, whereas several late acting cytokines (such as granulocyte-CSF [G-CSF] and erythropoietin [Epo] ) are crucial for the maturation of specialized progeny from these progenitors. As pure recombinant factors are now available and highly enriched populations of hematopoietic progenitors can be obtained for testing, their growth requirements have been further refined."" Most of the informati6n has been deduced using clonal assay systems for progenitors and has relied on the recognition of terminally differentiated progeny. Recently, in addition to these systems, suspension cultures have been used for the characterization of erythroidL6-l9 or granulocytic progenitor~.l~-~~ These systems are easier to manipulate and have confirmed to a large extent the growth requirements of progenitors and the factors needed for their amplification. However, because the results so far have been evaluated in end-stage progeny of these progenitors and because the culture systems used may contain undefined as well as defined factors, the implementation of the early transition from the progenitor stage to the stage of lineagespecific gene expression has not yet been delineated.
As far as the erythroid system is concerned, Epo is considered the major trigger of coordinate expression of many or all of the erythroid-specific Nevertheless, both with human and murine cells, culture systems have been devised that appear to bypass the need for Epo throughout the entire maturation sequence of erythroid However, even in these systems, the factors responsible for the initiation of transcription of erythroid-specific genes versus the factors required for completion of the maturation process have not been defined. Furthermore, because of the pharsystem do not all express a well-coordinated erythroid program accompanied by heme or glycophorin A expression and most die maintaining an immature state. Therefore, conditions that are responsible for initiation of globin expression in these cells are not sufficient to carry them to terminal maturation. The data point to an expanded target cell population for KL, as they suggest an influence of KL on survival and/or amplification of late erythroid cells previously thought to be influenced only by Epo. Our results in aggregate are of relevance to the physiology of normal erythropoiesis and the role of Epo and KL in the initial stages of lineage-restricted gene expression. In addition, they provide insight into the understanding of anemia in Wand Steel mutants in which expansion of the late erythroid progenitor pool, normally dependent on the synergistic action of KL and Epo, is curtailed. macologic concentrations of some of the factors used, it has been uncertain whether the in vitro data represent pathways operative in vivo.
To gain further insight into the sequence of events that are important during the early phases of erythroid progenitor (burst-forming unit-erythroid [BFUe]) differentiation and especially to identify factors that are needed to initiate the expression of specialized genes (ie, globin), we studied enriched populations of BFUe in a liquid suspension culture system, under conditions thought to promote or not to promote the generation of erythroid-differentiated progeny. In these studies, we focused our attention on changes within the first few days in liquid culture in an attempt to discover the initial decisions taken by the cells and the factors that may influence these decisions. We found that KL in synergy with I L 3 not only amplifies erythroid (and other) progenitors but it can influence the survival and/or the amplification of their descendants to the stage of globin-producing cells. However, these cells are unable to complete their maturation process and die prematurely in the absence of Epo. The data expand previous information pertaining to the physiology of normal erythropoiesis and to the role of KL in the early stages of expression of a specialized erythroid program.
MATERIALS AND METHODS

Cells
Mononuclear cells recovered after centrifugation of platelet apheresis collections were used as a source of cells for the majority of the experiments (provided by Dr Thomas Price, Puget Sound Blood Bank, Seattle, WA). These cell preparations consisted primarily of small lymphocytes with a proportion of monocytes and a very small and variable contamination with granulocytes and red blood cells (RBCs). When RBC contamination was significant, the cells were treated for 2 minutes at 37°C with a hemolytic buffer (0.83% NH4C1, 0.1% NaHCO,, 3.7 mg ?b EDTA) and washed with phosphate-buffered saline/bovine serum albumin (PBS/BSA; Dulbecco's Phosphate-Buffered Saline without calcium or magnesium; GIBCO, Grand Island, NY; with 1% BSA, Cohn Fraction V, Sigma, St Louis, MO, cat. no.
A-4503). Cells were then resuspended in Iscove's modified Dulbecco's medium (IMDM; GIBCO) with 5% fetal calf serum (FCS; Gemini Bioproducts, Calabasas, CA) and incubated for I hour at 37°C on Falcon tissue culture plates to remove the majority of adherent cells. Nonadherent cells were washed off the plates and transferred for direct immunoadherence to anti-CD34 (12.8) or SR-1 antibodycoated plates, as described below. In two experiments, instead of mononuclear cells from apheresis, peripheral blood was drawn from normal volunteers. In three experiments, bone marrow aspirates from normal volunteers were used. All procedures were in accordance with institutionally approved protocols and with informed consent. Peripheral blood and aspirated bone marrow were subjected to densitygradient (1.077) centrifugation on a cushion of Hypaque-Ficoll (Lymphoprep, Nygaard, Oslo). Mononuclear cells collected from the interface were washed and incubated for the 37°C adherence incubation step as described above.
Growth Factors
Human recombinant growth factors were used at previously determined optimal concentrations in both suspension and clonal cell cultures. IL-3 (Genetics Institute, Cambridge, MA) was used at 50 U/mL; KL (SCF Amgen, Thousand Oaks, CA) at 50 ng/mL; Epo (Genetics Institute) at 2 IU/mL; GM-CSF (Genetics Institute) at 45 ng/mL; and PIXY 32 I (a GM-CSF/IL-3 fusion protein; Immunex, Seattle, WA) at 10 pg/mL.
Antibodies
The following monoclonal antibodies (MoAbs) were used: anti-CD34, either HPCA-1 (Becton Dickinson, San Jose, CA) or 12.8 purified protein (provided by I.D. Bernstein, Seattle, WA) or biotinylated 12.8 (provided by R. Berenson, CellPro, Bothell, WA); antic-kit receptor antibody SR-13' (provided by V.C. Broudy, Seattle, WA); the antierythroid progenitor/erythroblast antibody EP-1 (developed in our laboratory3*); antiglycophorin (R-10; supplied by P.E. Edwards, London, UK); anti-IL-3 (a gift of K. Kaushansky, Seattle, WA); anti-Epo, polyclonal (Terry Fox Laboratories, Vancouver, BC, Canada); and the antiglobin antibodies (anti$ and anti-y) and their fluorescent conjugates (all produced in our laboratory). As secondary antibodies, goat antimouse IgG (H + L), F(ab)z-fluorescein isothiocyanate (FITC) (Hyclone, Logan, UT), or streptavidin-phycoerythrin (PE) (Biomeda, Foster City, CA) were used.
Surface Immunofluorescence
Live cells (about 5 X IO4 or more) in PBS/BSA were incubated with primary antibodies (anti-CD34, SR-I, EP-I, and R-10) at 4°C for 20 minutes at a concentration of 1:lOO or 1:200 for ascites or 5 to 25 pg/mL of purified antibody. Secondary antibody dilutions used varied from 1:20 to 1:50 depending on the lot. Treated cells were evaluated either with a Zeiss epifluorescence microscope (at 250X magnification) or by cytofluorometric analysis on an Ortho Cytofluorograf, model 50HH/2 150 (Ortho Diagnostic Systems, Westwood, MA) or FACStar Plus (Bector Dickinson).
In addition, in one experiment, CD34 Ad cells were doubly labeled with anti-CD34 ( 12.8 biotinylated antibody followed by streptavidin-PE) and EP-I antibody directly conjugated to FITC. These cells were analyzed and sorted with the FACStar Plus. Subsets that were either doubly positive (CD34+/EP-I+) or doubly negative (CD34-/EP-I-) for both antigens, or positive for only one of the two antigens (CD34+/ EP-1 -or CD34-/EP-1 +) were separated and used for further studies.
Antiglobin Labeling
The presence of 0-or y-globin was assessed by immunofluorescence on cytocentrifuge-prepared smears. These were fixed with methanol and treated with antiglobin MoAbs, as described previously.33 Briefly, antibody at optimal concentrations in solution in PBS/BSA was placed in a standing drop on fixed, rinsed, and dried cytocentrifuge smears and incubated for 30 minutes at 37°C in a moist chamber. Between antibody steps and after antibody labeling, slides were rinsed sequentially in PBS and water, air-dried, and observed in a Zeiss epifluorescence microscope. Double labeling using directly conjugated anti-0 or anti-y antibodies conjugated with FITC or rhodamine was also performed, as described above. In addition to fixed cell smears, cells from suspension cultures and controls were fixed with methanol in suspension, labeled with optimal dilutions of anti-0 or anti-y MoAbs, and subjected to cytofluorographic analysis.
Globin Messenger RNA (mRNA) Analysis
Globin RNA analysis was performed by a slot-blot hybridization assay developed in our lab~ratory.'~ Briefly, cells from suspension culture (0.2 to 1 X IO') were washed twice in PBS and resuspended in cold TE buffer (10 mmol/L Tris, 0.1 mmol/L EDTA) to which 20 U of RNase inhibitor was added (RNAsin; Promega, Madison, WI). After lysing the cells with 5% NP-40, the lysates were centrifuged and transferred to tubes containing SSC (0.15 mol/L NaC1, 0.015 mol/L trisodium citrate) and formaldehyde (6X SSC and 8% formaldehyde), denatured at 65'C for 15 minutes, and used for slot blotting immediately or stored at -70°C for later analysis.
For detection of P-globin mRNA, the 0.7-kb PstIIEcoRI fragment containing the 3' end of the human genomic @-globin was subcloned in the antisense orientation in T7 plasmid. For y-globin mRNA, the 0.6-kb EcoRIIHindIII fragment of the 3' end of Cy-globin gene was subcloned in a Sp6 vector. Hybridization conditions were as described34 and the relative amounts of y-and 0-globin mRNAs were calculated after phosphoimager analysis.
Benzidine Test
To assess heme content in cells, we used a sensitive (wet) benzidine assay as previously described3' or the method commonly used for fixed cell smears or fixed plasma clots.36
Immunoadherence ("anning'y
Immunoadherence of cells to Petri dishes precoated with MoAbs has been previously described by ourselves and other^.^',^' In the studies described here, Petri dishes were precoated with MoAb, either purified anti-CD34 (12.8) at 25 pg/mL or anti-c-kit (SR-I) ascites at 1:200 dilution, in 0.05 mol/L Tris buffer, pH 9.5, at room temperature for 45 minutes. Untreated cells in PBS/BSA were incubated directly on the panning plates for I hour at 4°C. After washing the nonadherent cells from the plates with cold PBS/BSA, adherent cells were incubated for 20 to 30 minutes at 37°C to loosen specifically adhering cells. Adherent cells were then recovered by flushing the plates with warm IMDM/FCS. "CD34 Ad" or "SR-1 Ad" cells were For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From incubated overnight at 37°C followed by, if enough cells were available, a second round of direct (anti-CD34 or SR-1) panning to further increase the specificity of adherence. Nonadherent cells from this second step, as well as adherent cells, were recovered and used for clonal or suspension cultures as described below.
Cell Cultures
After one or two rounds of direct panning, enriched progenitor populations were incubated at 37°C in stationary suspension culture in conical 15 mL polystyrene centrifuge tubes placed at a 25" angle. From 1 to 2 X IO5 cells/mL in 1 or 2 mL aliquots were cultured for 6 to 14 days. Eighty percent to 90% of the medium and additives were replaced every 48 hours. When aliquots of cells were removed for sampling, this was performed after mixing and replacing the medium, and cell determinations were based on per unit volume at each test day. The basic suspension medium was either serum-containing or serum-free. Serum-containing culture medium included 20% FCS and 10% human AB serum from normal volunteers (both heat-inactivated), I % BSA (Cohn Fraction V; Calbiochem, San Diego, CA), mol/L 2-mercaptoethanol (Eastman Kodak, Rochester, NY), and IMDM. Serum-free medium was composed of 90% Ex-cell 300 defined culture medium (JRH Bioscience, Lenexa, KS) supplemented with 1% BSA, ironsaturated human transfemn (early experiments were performed without additional supplementation with transfemn, relying only on the small amount of transfemn present in the Ex-cell 300), a mixture ofnucleosides (each at a final concentration of 10 pg/mL), mol/ L 2-mercaptoethanol, and L-glutamine. Growth factors or antibodies were added to these media in microliter amounts per milliliter.
Peripheral blood or bone marrow cells prepared as described above were cultured after each stage in the purification sequence (ie, before and after panning).38 Methylcellulose culture media contained the same components as the serum-supplemented suspension cultures with the addition of 1% methylcellulose (Fischer Scientific, Pittsburgh, PA). Plasma clot culture medium contained the same concentrations of FCS, AB serum, BSA, and 2-mercaptoethanol as the methylcellulose medium, but with the addition of bovine citrated plasma (Irvine Scientific, Irvine, CA) and beef embryo extract (GIBCO), each added at lo%, instead of methylcellulose. To these media the cytokines IL-3, KL, GM-CSF, and Epo, and the antibodies anti-Epo, anti-IL-3, and anti-c-kit (SR-1) were added alone or in various combinations. Colonies of different types were identified by morphologic criteria: colony-forming unit-erythroid (CFUe) in plasma clot cultures at days 5 to 7; BFUe, colony-forming unit-granulocyte and/or macrophage (CFU-GM), and CFU-Mix (one or more lineages in addition to erythroid) in live methylcellulose cultures at days 11 to 14. in the live cultures, BFUe colonies were large hemoglobinized, often multisegmented, and often macroscopic; CFU-GM were compact or loose colorless colonies; CFU-Mix colonies were large, sometimes multi-unit aggregates with both hemoglobinized and nonhemoglobinized portions. CFUe colonies were evaluated in flattened whole mounts of individual plasma clots fixed with glutaraldehyde and stained with benzidine and hematoxylin; they were defined as mature hemoglobinized, small compact clusters of 8 to 60 cells.
Liquid suspension cultures.
Clonal cultures.
RESULTS
Enrichment of Circulating Hematopoietic Progenitors by a Positive Immunoadherence Step
The adherent cells recovered after the first positive immunoadherence of peripheral mononuclear cells on anti-CD34-or SR-1 -coated plates represented approximately 1.2% to 2% of the initial cell population; adherent cells recovered after a second direct panning with the same antibodies were from 0.03 to 0.2% of the original cells. The cells from three normal bone marrow mononuclear cells were panned once and were on the average 2% of the initial cells.
Cells selected by panning with either anti-CD34 or SR-I appeared as small lymphocytes with a variable proportion of larger blast-like cells or monocytes. Positivity of "CD34 Ad" cells labeled with an anti-CD34 MoAb recognizing a different epitope (HPCA) from the one used for panning (12.8) was found to be from 40% to 70%. Positivity of "SR-1 Ad" cells was tested the day after panning with the SR-1 antibody, because an antibody to a different epitope was not available. The percent positive cells averaged 30% in three experiments when the total population was analyzed, but was greater than 80% when only the larger blast-like cells were gated.38
To assess the frequency of clonogenic progenitors in the "CD34 Ad" or "SR-I Ad" cells, we cultured them in clonal methylcellulose cultures under optimal conditions in the presence of IL-3, KL, GM-CSF, and Epo. The frequency of BFUe in these panned cells is shown in Table 1 . In nine experiments using "SR-I Ad" cells, the cloning efficiency of BFUe was from 2% to 27%, with a mean of 9.5% f 3.4% SEM, whereas frequencies before panning were from 0.02% to 0.44%. The frequency of BFUe in "CD34 Ad" cells in 16 experiments was from 5% to 24.6%, with a mean of 11.3% k 1.5% SEM. (Frequencies in CD34 nonadherent or SR-I nonadherent cells were much lower than in unseparated cells.) Large differences in enrichment among experiments may represent both biologic differences and possible differences in cell binding depending on whether ascites or purified antibody was used. Whenever two rounds of panning were used, enrichment improved, at the expense, however, of total progenitor yield (data not shown). Nevertheless, we were surprised to find that the progenitor purification and yield using only two rounds of direct panning without preliminary en- For personal use only. on October 22, 2017. by guest www.bloodjournal.org From richment of progenitors was comparable to those reported in previous studies using preliminary negative enrichment steps or FACS ~o r t i n g .~, " ,~~.~~ The b ursts from day 0 enriched cells were large, and a high proportion (about a third of the total) were macroscopic, containing over 10,000 cells. No CFUe-like colonies were seen in cultures from either peripheral blood or bone marrow "CD34 Ad" or "SR-1 Ad" cells. No hemoglobinized colonies were usually observed in the absence of Epo in these cultures. Recovery of original BFUe in the adherent cell samples (calculated as numbers of BFUe in the "panned" population divided by the number of BFUe in the original population) showed a wide variation (range, 2% to 70%), but was usually above 15%.
Cell Proliferation and BFUe Amplification in Short-Term Liquid Cultures: The Efect of Cytokines
Cell proliferation was assessed by cell counts in all suspension culture experiments on days 6 and 7 and up to 2 weeks in certain experiments. In the absence of growth factors, no cell growth was noted compared with the input number of cells (data not shown). However, in the presence of IL-3 and KL, there was a significant increase in cell number over a 6-day period, of up to 18-fold among the 19 experiments performed. In the presence of a single cytokine, ie, IL-3 or KL or Epo, there was less growth (up to 4-fold) during the same 6-to 7-day period.
The number of progenitors present after 1 week in suspension culture was assessed by secondary plating in clonal methylcellulose culture. The frequency of BFUe (after 6 days in suspension) ranged from I% to 53% (Table 2) . Highest frequencies again were observed after suspension culture in IL-3 and KL compared with either of these cytokines alone.
BFUe amplification at day 6 over the number at day 0 was from threefold to 40-fold, with a mean of 1 1-fold k 2.7-fold SEM and occurred in all cultures containing combinations of cytokines (Fig 1) . Such increments in cell proliferation and progenitor amplification are in keeping with prior studies of enriched progenitors from bone marrow or peripheral blood from our own and other l a b o r a t~r i e s .~* " *~~~~*
Morphologic Changes and Generation of Globin(+) Cells in Suspension Cultures of Enriched Progenitors
In addition to testing cell proliferation and progenitor amplification by cell counting and clonal assays for progenitors, cytospin preparations were prepared routinely after 1 week in suspension culture and in selected experiments on days 2, 4, 6, 10, and 12. Preparations from cultures without cytokines showed many unhealthy cells and minimal differentiation. However, cultures containing cytokines, especially those containing IL-3 and KL, showed healthy populations of immature blasts ranging from 20% to more than 50%, depending on the experiment (Fig 2) . The small lymphoid cells seen at day 1 have greatly diminished or virtually disappeared by day 6. In addition to blast-like cells, immature cells with basophil-like granules were present (Fig 2) in Wright's-Giemsa-stained preparations. The same populations were also tested for benzidine positivity (by the wet benzidine method) and for the presence of p-or y-globin using monoclonal anti-@ and antiy antibodies, as described in Materials and Methods. Wet benzidine staining, always negative in day 0 to 1 preparations, ranged from 1% to 20% at days 6 to 7 (Table 3) . Benzidine positivity in dried smears was always much lower or totally negative (data not shown). Frequencies of ant@ or anti-y Cultures containing cytokines but excluding Epo. For
in which we used anti-c-kit receptor antibody (SR-I). The results of these experiments are shown in Table  2 . The presence of SR-1 in suspension culture dramatically reduced not only cell proliferation and amplification of BFUe but also the generation of &globin(+) cells. In previous experiments, we showed that the addition of SR-I to Epo-or 1L-3-containing clonal cultures profoundly reduced the number of erythroid burst^,^'.'^ implying that c-kit receptor function in the context of IL-3 or Epo is very important for BFUe development. This conclusion was later independently confirmed by other appro ache^.^.^' Here we show in addition that kit ligand/receptor interactions are crucial for the generation ofglobin(+) cells in suspension culture. The presence of anti-113 antibody in cultures containing IL-3 and KL did not diminish the effectiveness of KL, although complete neutralization of IL-3 was not proven in these experiments. Furthermore, the action of KL or Epo alone in suspension cultures did not seem to be influenced by putative endogenously produced IL-3 (Table 2) .
Culrirres 2).
globin-positive cells are shown in Tables 2 through 4 and Figs 3 and 4. In 14 experiments, they ranged from 4% to 38% at day 6 to 7, and the frequency of BFUe in the same cell populations was from 4% to 53% (Tables 2 through 4) . Thus, cultures containing IL-3 and KL contained a large proportion of erythroid cells at the BFUe level and at the globin-synthesizing cell level. Surface labeling of these populations was performed in selected experiments using anti-CD34, SR-I, EP-I, and antiglycophorin A antibodies. A significant decrease (more than two-thirds) in both CD34-and SR-l-positive cells was observed at day 7 compared with day 0 (data not shown). In contrast, EP-I positivity increased from about 5% to 10% at day 0 to greater than 50% at day 6. Glycophorin A was negative at day 0 in "CD34 Ad" cells prepared from either peripheral blood or bone marrow, but these cells became 15% to 33% positive at day 6 to 7. Frequency of glycophorin A-positive cells was usually less (by one-third to one-fifth) than the frequency of globin(+) cells. When IL-3 or KL were each used alone, not only was there less amplification in cell numbers and in progenitors, but also the number of globin(+) cells generated were greatly diminished (Fig I) .
To gain further insight into the synergistic action of IL-3 or KL when they were used in combination, we performed Table 2. §Different SF than in experiments 3 through 5.
globin(+) cells declined in IL-3 + KL cultures (Fig 3) without any evidence of further maturation. In contrast, globin(+) cells in Epo-containing cultures increased to more than 90% (Fig 3) by day 13 to 14, accompanied by an accumulation of smaller, more mature, strongly benzidine(+) cells. In a few experiments, in addition to anti-@-globin labeling, cytospin preparations from six cultures (with or without Epo) were doubly labeled with an anti-y-globin antibody. Cells positive for y-globin were also positive for &globin, and therefore did not represent a separate population. Overall, the proportion of benzidine(+) cells was lower than that of P-globin(+) cells; this was especially true in serum-free medium and in the absence of Epo.
Liquid Cultures in Serum Versus Serum-Free Medium
In five experiments we compared the results of combinations of cytokines and Epo in the presence or absence of serum. Under serum-free conditions, cell proliferation and BFUe amplification were comparable to serum-containing cultures and there were no significant differences in the generation of &globin(+) cells (Table 3 ). However, replicate For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From
Experiments With Anti-Epo
The above results with serum-free cultures suggested that Epo is not critical for the generation of globin(+) cells in IL-3 + KL-containing cultures (Table 3) . To further pursue whether any endogenous Epo was present in the system, we performed three experiments in which anti-Epo neutralizing polyclonal antibodies were included in the serum-free culture medium in the presence and in the absence of Epo. In clonal culture controls, these antibodies were found to neutralize the Epo effect, as no mature bursts were observed in meth- preparations stained with anti-y-globin showed a consistent and significant decrease in the proportion of y-globin cells in serum-free conditions compared with serum-containing ones, with all combinations of cytokines tested (IL3, KL, or Epo). Thus, the effect of serum-free conditions on y-globin synthesis noted in previous clonal c~l t u r e s~~*~* *~~ appears to be confirmed here and to be dominant regardless of the combination of cytokines used. For example, no consistent trend in proportion of y-globin was found when cultures containing KL (at 50 pg/mL) were compared with cultures containing only Epo. The differences in 'Y-globin (between serum-contahing and serum-free cultures) seen with fluorescent-labeled antiglobin antibodies were confirmed at the mRNA level in slot-blot hybridization assays (~i~ 5). I~ cultures without serum* ?dobin mRNA was either veq low Or bare1y detectable compared with &globin mRNA. For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From ylcellulose cultures in the simultaneous presence of Epo and anti-Epo (data not shown). Anti-Epo was added to suspension cultures on day I (at concentrations sufficient to overcome three times the level of Epo used), and fresh medium containing anti-Epo was added every 2 days for I week. The amplification in BFUe and CFU-GM and the generation of globin(+) cells was assessed in the presence of anti-Epo (in suspension cultures) with several cytokine combinations. When anti-Epo was added to suspension cultures containing Epo only, there was a drastic reduction in the expansion of BFUe (assessed by replating cells in Epo-containing clonal cultures) and in the generation of D-globin(+) cells, to levels observed without any growth factor (Table 4) . When antiEpo was added to cultures containing IL-3 and KL, there were no significant effects in serum-free cultures, although some effect was noted in serum-containing cultures (Table  4 ). In the presence of serum, in addition to a decrease in BFUe, a reduction in the amplification of CFU-GM was found; this could be explained at least in part as a nonspecific effect ofthe antibody (a rabbit polyclonal antiserum) on progenitor clonal development.
Experimenfs With An1i-CD34 and EP-I Doubly Labeled Cells
Previous experiments'* have shown that EP-I antibody reacts preferentially with erythroid (BFUe) rather than nonerythroid progenitors. To study the nature of the immediate precursors of the globin(+) progeny in our suspension cultures and/or to enrich for these precursor cells, we doubly labeled the CD34 Ad cells with anti-CD34 and EP-1 the day after panning. The proportion of each subset (+/+, -/+, +/-, -/ -) in the total population was recorded; aliquots of each subset were immediately plated in clonogenic progenitor assays and in suspension culture in the presence of I L 3 and KL. After 6 days in suspension, cell numbers, frequency of clonogenic progenitors, and frequency of globin(+) cells were determined. As shown in Table 5 , although the CD34-/EP-1+ subset represented only 15% of the total population, it had the highest frequency of BFUe at day 0. This subset not only maintained the highest frequency of BFUe and CFUe in suspension culture, but, most impressively, led to the highest total number (and highest frequency) of globin( +) cells in suspension culture, suggesting that CD34-/EP-1+ cells are the immediate progenitors of most globin(+) cells in unsorted populations. The doubly positive subset (CD34+/EP-I+) gave rise to less BFUe than the previous subset, but these were larger in size and appeared to have expanded more during the 6-day period in suspension culture than those from the CD34-/EP-l+ cells. These data are consistent with the notion that CD34+/EP-I + are more primitive erythroid progenitors than CD34-/EP-l+. The subset that was least positive or negative for EP-I but still positive for CD34 (CD34+/EP-1 -) appeared to have the highest proportion of CFU-GM (9%); these were greatly expanded by day 6 to constitute 15% of the whole population, in contrast to all other subsets that For personal use only. on October 22, 2017. by guest www.bloodjournal.org From had less than 1%. BFUe present in this subset were nearly all (96%) of large size. Collectively, these data provide new information about the phenotypic heterogeneity of BFUe and suggest a developmental hierarchy, from CD34+/EP-1 to CD34+/EP-lf to CD34-/EP-l+.
DISCUSSION
In the studies presented here, we have focused our attention on the detection and evaluation by sensitive approaches of newly acquired erythroid differentiation features when enriched populations of erythroid progenitors are placed in suspension culture under the influence of various hematopoietic cytokines. Specifically, the effects of early cytokines, such as KL or IL-3, were studied and the data were compared with control cultures containing Epo. The major findings from our studies are: (1) the consistent generation from normal BFUe of a significant number of Epo-independent globinsynthesizing cells during 1 week in suspension culture; (2) KL in synergy with IL-3 is instrumental in the accumulation of these globin-containing cells, suggesting that it can influence cells previously thought to be exclusively influenced by Epo; (3) globin appears to be an earlier rather than a later marker of erythroid differentiation and conditions that initiate its synthesis in cultures without Epo are not sufficient alone to carry the cells through their terminal maturation.
Several lines of evidence in our work suggest that neither extraneously provided nor endogenously produced Epo is critical for the formation of the globin synthesizing BFUe progeny. Results of experiments performed in serum-free, chemically defined media or in the presence of neutralizing anti-Epo antibodies argue against the need for the presence of Epo in our system (Tables 3 and 4) . However, the above data do not exclude the possibility of an autocrine regulation by a certain class of erythroid progenitors (CFU-Mix), as suggested by a recent report." Preliminary experiments using our culture system with the enriched CD34 Ad population rather than the unpurified bone marrow cells used in the previous report have failed to detect, by reverse transcriptionpolymerase chain reaction (RT-PCR) or RNase protection assays, any Epo mRNA either at day 0 or after suspension culture for 1 week with IL-3 and KL. Furthermore, using the same antisense strategy used in the previously published work44 with our culture system (with two sense and two antisense oligonucleotides, freshly renewed every 48 hours in serum-free cultures), we failed to uncover differences between sense-and antisense-containing cultures (data not shown).
Our results, ie, the regeneration of Epo-independent globinsynthesizing cells in suspension, are at variance with several previous reports using suspension cultures supplemented with hematopoietic cytokines, in which no detectable erythroid differentiation was seen in the absence of added Ep0.16-'9.22323 Their conclusions were based on the absence of benzidine positivity or absence of glycophorin A positivity. However, these results may not necessarily be contradictory to our own but instead may be attributable to differences in the sensitivity of the approaches used (ie, globin positivity versus benzidine or glycophorin A positivity) and to the fact that we have used enriched progenitor populations.
Although our demonstration of globin(+) cells in suspension cultures lacking Epo is novel, in clonal cultures the development of erythroid characteristics under conditions of Epo deprivation has been documented by several laboratories. For example, this result is observed routinely with cells from patients with myeloproliferative syndromes45448 and to a lesser extent in situations with expanded erythr~poiesis."~'~~ Furthermore, under special conditions, hemoglobinized colonies can develop from normal progenitors if specific additives, such as IGF-I, IGF-11, hemin, or retinoids (usually in pharmacologic doses) are used instead of E~o .~' There are major differences between this previous clonal culture system using normal individuals3' and our own suspension system. First, no special components were used in our cultures, ie, no IGF, hemin, or retinyl-acetate. In fact, our serum-free conditions were so minimal that the same medium used in methylcellulose clonal cultures was inadequate for clonal growth of the same progenitors. Second, in contrast to this previous re~ort,~' accessory cells were not needed in our suspension culture system. Furthermore, whereas our system does not support the full maturation of erythroid cells in the absence of Epo, we are able to identify them early without the need for color (heme) formation. Despite the above differences, however, a common denominator between our suspension system and previous clonal cultures (with either normal m~r i n e~~'~~ or normal humanm progenitors) was the presence of cytokines, either in purified form or in the form of conditioned media. It would appear that the presence of cytokines ( I L 3 and KL) in the absence of Epo is important for the early stages of erythroid-specific gene expression (ie, globin synthesis) and for formation of the cells we are detecting, whereas other factors (such as Epo, insulin, activin, hemin, or IGF-I and 11) are needed for enhancing their further maturation. In addition to their cytokine requirements, questions pertaining to the identity, the state of differentiation, and the fate of these globin(+) cells in suspension culture were addressed in our studies. By morphologic criteria, these globin(+) cells, with immature nucleus and deep basophilic cytoplasm with perinuclear clear zone, resemble cells at the CFUe/proerythroblast 1e~el.l~ However, we do not think that these cells are descendants of CFUe; instead, we believe that they are likely generated directly from late BFUe or pre-CFUe with a CD34-/EP-1+ phenotype. Several pieces of evidence favor this view: during the 6 days in non-Epo suspension cultures, CFUe, originally absent at day 0, never become more prevalent than either BFUe or globin(+) cells (Tables 2 and 4); this holds true under conditions that either increase (Fig 1) or curtail (Table 2 ) BFUe output; double-labeling experiments with EP-1 and CD34 point to a subset of CD34-/ EP-1' cells that give rise to many late BFUe colonies at day 0 and generate more globin(+) cells by day 6 than any other subset (Table 5) ; again in this subset, both BFUe (mostly late) and globin(+) cells were higher than CFUe up to 6 days in suspension culture (Table 5 ). Whatever their stage of differentiation might be (pre-CFUe or CFUe-like), the day 6 globin(+) cells do not appear to mature when cultures are prolonged; they die retaining their immature state. This may be the main reason why this population, although generated regularly in small numbers (as small colonies) in standard clonal cultures, especially those with IL-3 or KL but no Epo For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From (Th. Papayannopoulou, unpublished data), is not usually recognized. Their presence is probably evanescent, and they die if Epo is not continuously present. Thus, although their generation in vitro (in the presence of IL-3 or KL) is Epoindependent, their further amplification and maturation under ordinary culture conditions is absolutely dependent on Epo. Whether erythroid cells at their earliest stages of differentiation express a different Epo receptor isoform, thus contributing to their apoptotic death, as it has been recently sugg e~t e d ,~* remains to be seen.
Is the generation of globin(+) cells under our culture conditions only an in vitro phenomenon, or does it have any relevance to in vivo differentiation? Although our culture conditions contain rather high levels of powerful cytokines, we believe that this population is generated in vivo as well. Such cells usually escape detection as their numbers are very low and their only recognizable characteristic may be the presence ofglobin. The fact that rare globin(+) blast-like cells were seen in some of our preparations of circulating purified progenitors at day 0 favors the notion that this population does exist in vivo.
Recently, evidence was presented that KL increases the proportion of HbF in clonal cultures of human progenitors, both in serum-containing and serumdeprived cultures. The mechanism(s) by which KL in synergy with IL-3 leads to accumulation of globin(+) cells is of extreme interest and requires further study. It is unclear from our data whether KL influences only the survival and/or proliferation of spontaneously generated globin( +) cells or, in addition, enhances their direct generation from BFUe. It is possible that, under the synergistic influence of KL, pivotal erythroid specific transcriptional factors, such as GATA-1 ,54 are upregulated in BFUe progeny in the absence of Epo ligand/receptor induced interaction^.^^ Indeed, in preliminary experiments we have observed such a GATA-1 upregulation (unpublished data) in IL-3 + KL-containing cultures. Upregulation of GATA-1 in non-Epo-containing cultures (also observed by Sposi et alS6) may explain the early appearance of globin(+) cells in these cultures. However, it does not seem to be sufficient for continuing maturation and expression of a wellcoordinated erythroid program. In this context, it is of interest that the phenotype of our globin(+) cells is reminiscent of the phenotype of many human33 and murine (ME-26)57 erythroleukemia cells and cell lines, which express significant levels of GATA-1 and globin, but relatively little or no heme and for the most part fail to mature. However, one difference between these leukemic cells and the normal cells studied here is that Epo can induce maturation in the normal cells, but it cannot d o so in most leukemic cell lines.
We believe that our results provide new information of relevance to the understanding of early events in erythropoiesis, as they expand the target cell repertoire for KL to include cells (eg, at the CFUe level) thought to be influenced by Epo only. Any KL or anti-c-kit effect on survival and/or amplification of these cells would be masked when Epo is present at full doses ( Table 2 ). This would also reconcile the previously reported absence of KL effect on CFUe, as it was tested in Epo-containing cultures.38 In addition to their direct bearing on the physiology of erythropoiesis, our observations may provide an insight into the predominant effect of KL on in vivo erythropoiesis in W and Steel mutant mice. As implied by our in vitro data, and in concert with a previous For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From
